share_log

賽生藥業：董事會會議召開日期

SCICLONE PHARMA: DATE OF BOARD MEETING

香港交易所 ·  Mar 18 00:01
Summary by Moomoo AI
賽生藥業控股有限公司（「本公司」）將於2024年3月28日（星期四）召開董事會會議，屆時將考慮並批准截至2023年12月31日止年度的末期業績及建議末期股息。會議將由執行董事趙宏先生及潘蓉容女士，以及其他董事會成員共同出席，處理相關財務報告事宜及其他公司事務。
賽生藥業控股有限公司（「本公司」）將於2024年3月28日（星期四）召開董事會會議，屆時將考慮並批准截至2023年12月31日止年度的末期業績及建議末期股息。會議將由執行董事趙宏先生及潘蓉容女士，以及其他董事會成員共同出席，處理相關財務報告事宜及其他公司事務。
Caiseng Pharmaceutical Holdings Limited (the “Company”) will hold a Board meeting on Thursday, March 28, 2024, at which time the final results and the proposed final dividend for the year ended December 31, 2023 will be considered and approved. The meeting will be attended by the Executive Director Mr. Zhao Hong and Ms. Pan Rong Yong, as well as other members of the Board of Directors to deal with related financial reporting matters and other corporate matters.
Caiseng Pharmaceutical Holdings Limited (the “Company”) will hold a Board meeting on Thursday, March 28, 2024, at which time the final results and the proposed final dividend for the year ended December 31, 2023 will be considered and approved. The meeting will be attended by the Executive Director Mr. Zhao Hong and Ms. Pan Rong Yong, as well as other members of the Board of Directors to deal with related financial reporting matters and other corporate matters.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more